Cargando…
A developed model of cancer patients participation in intravenous chemotherapy safety
How to reduce intravenous chemotherapy-related adverse reactions of cancer patients is one focus of clinical work. Nowadays, patient for patient safety (PFPS) is an important component of hospital safety management and can contribute to a reduction in the rate of adverse events following intravenous...
Autores principales: | Na, Zeng, Qiaoyuan, Yan, Binghan, Wang, Qin, Zhu, Yue, Chen, Xin, Peng, Cuilian, Tan, Cheng, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675656/ https://www.ncbi.nlm.nih.gov/pubmed/29152104 http://dx.doi.org/10.18632/oncotarget.20986 |
Ejemplares similares
-
Efficacy and Safety of Thalidomide for Chemotherapy-induced Nausea and Vomiting
por: Wang, Nan, et al.
Publicado: (2020) -
Pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose intravenous ceftobiprole in healthy Chinese participants
por: Li, Wan-Zhen, et al.
Publicado: (2021) -
Silencing of lncRNA AFAP1-AS1 suppressed lung cancer development by regulatory mechanism in cis and trans
por: Peng, Baoying, et al.
Publicado: (2017) -
Adjuvant chemotherapy or no adjuvant chemotherapy? A prediction model for the risk stratification of recurrence or metastasis of nasopharyngeal carcinoma combining MRI radiomics with clinical factors
por: Wu, Qiaoyuan, et al.
Publicado: (2023) -
Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer
por: Peng, Shu hui, et al.
Publicado: (2021)